These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 14411082)

  • 21. Pharmacology update. Hypnotic agents.
    Romankiewicz JA
    J Pract Nurs; 1979 Nov; 29(11):11-3. PubMed ID: 259653
    [No Abstract]   [Full Text] [Related]  

  • 22. [Evaluation of the hypnotic properties of nitrazepam (Mogadon) in insomnia in mental patients].
    Tétreault L; Huot J; Bordeleau JM
    Union Med Can; 1966 Dec; 95(12):1392-400. PubMed ID: 4870760
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical and statistical evaluation of six hypnotic agents.
    le RICHE W; van BELLE
    Can Med Assoc J; 1963 Apr; 88(16):837-41. PubMed ID: 13982136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced sensitivity to some drugs 48 h after chlorpromazine treatment.
    KATO R
    Experientia; 1960 Sep; 16():427-8. PubMed ID: 13751770
    [No Abstract]   [Full Text] [Related]  

  • 25. A research note on some of the critical factors on the dissimilar effects of chlorpromazine and secobarbital on the digit symbol substitution and continuous performance tests.
    Kornetsky C; Orzack MH
    Psychopharmacologia; 1964 Jul; 6(1):79-86. PubMed ID: 5318645
    [No Abstract]   [Full Text] [Related]  

  • 26. The effects of chlorpromazine and secobarbital on matching from sample and discrimination tasks in monkeys.
    Pragay EB; Mirsky AF; Abplanalp JM
    Psychopharmacologia; 1969; 16(2):128-38. PubMed ID: 4983119
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of secobarbital and chlorpromazine on cortical and subcortical visual-evoked potentials in the monkey [proceedings].
    Pragay EB; Mirsky AF
    Psychopharmacol Bull; 1977 Apr; 13(2):61-4. PubMed ID: 404658
    [No Abstract]   [Full Text] [Related]  

  • 28. Chemistry and pharmacology of compounds related to 4-(4-hydroxy-4-phenyl-piperidino)-butyrophenone. III. Duration of antiemetic action and oral effectiveness of Haloperidol (R 1625) and of chlorpromazine in dogs.
    JANSSEN PA; NIEMEGEERS CJ; SCHELLEKENS KH
    Arzneimittelforschung; 1960 Nov; 10():955. PubMed ID: 13789501
    [No Abstract]   [Full Text] [Related]  

  • 29. The effects of chlorpromazine and secobarbital under two conditions of reinforcement on the performance of chronic schizophrenic subjects.
    Latz A; Kornetsky C
    Psychopharmacologia; 1965 Feb; 7(2):77-88. PubMed ID: 5318925
    [No Abstract]   [Full Text] [Related]  

  • 30. A CLINICAL EVALUATION OF FOUR HYPNOTIC AGENTS, USING A LATIN-SQUARE DESIGN.
    LERICHE WH; CSIMA A
    Can Med Assoc J; 1964 Aug; 91(9):435-8. PubMed ID: 14179064
    [TBL] [Abstract][Full Text] [Related]  

  • 31. VISUALLY EVOKED RESPONSES IN MAN: A METHOD FOR MEASURING CEREBRAL EFFECTS OF PREANESTHETIC MEDICATION.
    CORSSEN G; DOMINO EF
    Anesthesiology; 1964; 25():330-41. PubMed ID: 14156574
    [No Abstract]   [Full Text] [Related]  

  • 32. EEG correlates of impaired attention performance under secobarbital and chlorpromazine in the monkey.
    Mirsky AF; Tecce JJ; Harman N; Oshima H
    Psychopharmacologia; 1975; 41(1):35-41. PubMed ID: 1124267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparative controlled clinical trial of seven hypnotic agents in medical and psychiatric in-patients.
    RICKELS K; BASS H
    Am J Med Sci; 1963 Feb; 245():142-52. PubMed ID: 13982205
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of chlorpromazine, secobarbital and sleep deprivation on attention in monkeys.
    Mirsky AF; Bloch S
    Psychopharmacologia; 1967; 10(5):388-99. PubMed ID: 4968313
    [No Abstract]   [Full Text] [Related]  

  • 35. [Experimental studies on the influence of chlorpromazine, isomytal and meprobamate on the carbohydrate metabolism of isolated tissues, with special reference to the behavior of brain slices].
    KOIZUMI H
    Naika Hokan; 1961; 8():167-83. PubMed ID: 13757638
    [No Abstract]   [Full Text] [Related]  

  • 36. Chemistry and pharmacology of compounds related to 4-(4-hydroxy-4-phenyl-piperidino)-butyrophenone. IV. Influence of haloperidol (R 1625) and of chlorpromazine on the behaviour of rats in an unfamiliar "open field" situation.
    JANSSEN PA; JAGENEAU AH; SCHELLEKENS KH
    Psychopharmacologia; 1960 Sep; 1():389-92. PubMed ID: 13789498
    [No Abstract]   [Full Text] [Related]  

  • 37. Potentiation of hypnotics and analgesics; clinical experience with chlorpromazine.
    WALLIS R
    N Y State J Med; 1955 Jan; 55(2):243-5. PubMed ID: 13224013
    [No Abstract]   [Full Text] [Related]  

  • 38. [Substances interfering with the hypnotic-potentiating activity of serotonin].
    GARATTINI S; VALZELLI L
    Boll Soc Ital Biol Sper; 1956; 32(3-5):292-5. PubMed ID: 13342261
    [No Abstract]   [Full Text] [Related]  

  • 39. A study on the comparative depressant effects of hypnotic drugs, medomin, seconal and phenobarbital, on heart muscle and cardiac vagus nerve.
    HALBEISEN WA; GRUBER CM; GRUBER CM
    Anesthesiology; 1949 Sep; 10(5):585-9. PubMed ID: 18138127
    [No Abstract]   [Full Text] [Related]  

  • 40. The nature of performance deficity under secobarbital and chlorpromazine in the monkey. A behavioral and EEG study.
    Pragay EB; Mirsky AF
    Psychopharmacologia; 1973; 28(1):73-85. PubMed ID: 4197518
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.